These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Reply to IL-18 is not therapeutic for neovascular age-related macular degeneration. Doyle SL; Adamson P; López FJ; Humphries P; Campbell M Nat Med; 2014 Dec; 20(12):1376-7. PubMed ID: 25473915 [No Abstract] [Full Text] [Related]
3. Eye diseases: a new use for interleukin-18 in sight. Bray N Nat Rev Drug Discov; 2014 Jun; 13(6):418. PubMed ID: 24833293 [No Abstract] [Full Text] [Related]
5. Therapeutic approaches for vision loss due to choroidal neovascularizations in age related macular degeneration. Costagliola C Curr Drug Targets; 2011 Feb; 12(2):133-7. PubMed ID: 20887248 [No Abstract] [Full Text] [Related]
6. Towards a rational approach to combination therapy for neovascular age-related macular degeneration. Arroyo JG Br J Ophthalmol; 2007 Feb; 91(2):130-1. PubMed ID: 17244655 [TBL] [Abstract][Full Text] [Related]
7. A very effective treatment for neovascular macular degeneration. Stone EM N Engl J Med; 2006 Oct; 355(14):1493-5. PubMed ID: 17021326 [No Abstract] [Full Text] [Related]
8. [Results of photodynamic treatment of choroidal neovascular membrane in age-related macular degeneration]. Dubská Z; Kalvodová B Cas Lek Cesk; 2006; 145(10):800, 802-3. PubMed ID: 17121073 [No Abstract] [Full Text] [Related]
9. Photodynamic therapy with verteporfin is effective for selected patients with neovascular age-related macular degeneration. Fine SL Arch Ophthalmol; 1999 Oct; 117(10):1400-2. PubMed ID: 10532450 [No Abstract] [Full Text] [Related]
11. Hot Topics in Pharmacotherapy for Neovascular Age-Related Macular Degeneration. Falavarjani KG; Sadda SR Curr Pharm Des; 2017; 23(4):535-541. PubMed ID: 27981904 [TBL] [Abstract][Full Text] [Related]
12. The Therapeutic Conversation and a Holistic Approach to the Management of Patients with Neovascular Age-Related Macular Degeneration. Cackett PD; Young SL Ophthalmologica; 2022; 245(4):393-394. PubMed ID: 35477167 [No Abstract] [Full Text] [Related]
13. [Introduction to the topic: Off-label use of bevacizumab in the treatment of neovascular age-related macular degeneration]. Bartz-Schmidt KU; Holz FG Ophthalmologe; 2006 Jun; 103(6):461-2. PubMed ID: 16763861 [No Abstract] [Full Text] [Related]
14. Managing neovascular age-related macular degeneration: a step into the light. Guymer RH Med J Aust; 2007 Mar; 186(6):276-7. PubMed ID: 17371204 [No Abstract] [Full Text] [Related]